Dreman Value Management Upped Pfizer (PFE) Holding By $360,815; IDEXX Laboratories, Inc. (IDXX) Covered By 7 Bulls

February 23, 2018 - By reb123z

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories had 27 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Bank of America on Friday, February 2. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Buy” rating given on Monday, October 23 by Stifel Nicolaus. The firm has “Market Perform” rating by Raymond James given on Friday, August 28. The firm has “Buy” rating given on Thursday, February 1 by Stifel Nicolaus. Stifel Nicolaus maintained IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Monday, March 21 with “Buy” rating. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, August 21. The stock has “Outperform” rating by Credit Suisse on Wednesday, April 13. Bank of America reinitiated the stock with “Neutral” rating in Thursday, September 29 report. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Sell” rating given on Friday, February 3 by Feltl & Co. The rating was upgraded by Feltl & Co on Friday, July 24 to “Hold”. See IDEXX Laboratories, Inc. (NASDAQ:IDXX) latest ratings:

02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $200 New Target: $220 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $215.0 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $211.0
29/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $210.0 Maintain
16/01/2018 Broker: PiperJaffray Rating: Overweight New Target: $200 Initiates Coverage On
23/10/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $185.0 Maintain
05/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $180.0 Maintain

Dreman Value Management Llc increased Pfizer Incorporated (PFE) stake by 54.54% reported in 2017Q3 SEC filing. Dreman Value Management Llc acquired 10,309 shares as Pfizer Incorporated (PFE)’s stock declined 3.45%. The Dreman Value Management Llc holds 29,210 shares with $1.04M value, up from 18,901 last quarter. Pfizer Incorporated now has $214.97B valuation. The stock increased 0.91% or $0.325 during the last trading session, reaching $36.065. About 5.10M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since February 23, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer had 74 analyst reports since July 29, 2015 according to SRatingsIntel. Morgan Stanley upgraded Pfizer Inc. (NYSE:PFE) rating on Friday, October 2. Morgan Stanley has “Overweight” rating and $38 target. As per Wednesday, October 28, the company rating was maintained by Deutsche Bank. The firm has “Hold” rating given on Thursday, July 13 by Jefferies. Leerink Swann maintained it with “Market Perform” rating and $38 target in Wednesday, January 31 report. SunTrust maintained it with “Hold” rating and $33.0 target in Monday, October 16 report. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Tuesday, June 14 by Jefferies. The firm has “Hold” rating given on Tuesday, January 16 by Jefferies. Cowen & Co maintained it with “Buy” rating and $4300 target in Monday, July 10 report. The firm has “Buy” rating given on Wednesday, July 29 by Argus Research. The firm has “Hold” rating by Argus Research given on Wednesday, November 2.

Dreman Value Management Llc decreased Ca Inc Common Stock Usd.1 (NASDAQ:CA) stake by 10,230 shares to 31,682 valued at $1.06M in 2017Q3. It also reduced American Financial Group Inc. (NYSE:AFG) stake by 5,223 shares and now owns 70 shares. Orbital Atk Inc. was reduced too.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It increased, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Lincoln National owns 60,433 shares. Lingohr And Partner Asset Mngmt Gmbh stated it has 36,700 shares or 0.66% of all its holdings. Illinois-based Old Second Comml Bank Of Aurora has invested 1.73% in Pfizer Inc. (NYSE:PFE). Eulav Asset Mngmt stated it has 0.17% of its portfolio in Pfizer Inc. (NYSE:PFE). Capital Intl Sarl, a California-based fund reported 30,700 shares. Goldman Sachs Group reported 49.53M shares or 0.43% of all its holdings. Citadel Llc invested in 6.93 million shares or 0.19% of the stock. Benjamin F Edwards & holds 96,317 shares. Autus Asset Mngmt Ltd Com holds 7,240 shares. Fukoku Mutual Life Ins Company holds 2.15% or 407,854 shares. Halsey Associate Ct stated it has 0.2% of its portfolio in Pfizer Inc. (NYSE:PFE). Horrell Capital Management stated it has 159 shares or 0% of all its holdings. Peak Asset owns 0.51% invested in Pfizer Inc. (NYSE:PFE) for 40,188 shares. Moreover, Wealthtrust Axiom has 1.24% invested in Pfizer Inc. (NYSE:PFE) for 91,558 shares. Evermay Wealth Management Limited Liability Company accumulated 48,543 shares or 0.75% of the stock.

Since August 31, 2017, it had 0 insider purchases, and 7 sales for $12.30 million activity. On Thursday, August 31 the insider READ IAN C sold $6.70M. MACKENZIE ALEXANDER R also sold $249,750 worth of Pfizer Inc. (NYSE:PFE) on Friday, December 15. $3.21 million worth of Pfizer Inc. (NYSE:PFE) was sold by DAMELIO FRANK A on Thursday, August 31. $1.34 million worth of Pfizer Inc. (NYSE:PFE) was sold by SUSMAN SALLY. Another trade for 8,000 shares valued at $296,560 was made by JOHNSON RADY A on Friday, December 15.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company has market cap of $16.12 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions. It has a 62.91 P/E ratio. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

The stock increased 0.60% or $1.11 during the last trading session, reaching $184.97. About 100,309 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since February 23, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

Since August 28, 2017, it had 2 insider purchases, and 5 selling transactions for $22.12 million activity. On Monday, August 28 AYERS JONATHAN W sold $1.96 million worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 13,000 shares. Kingsley Lawrence D had bought 1,000 shares worth $178,045 on Wednesday, February 14. Another trade for 6,602 shares valued at $1.20 million was made by MCKEON BRIAN P on Monday, February 5. Claflin Bruce L. had bought 1,000 shares worth $179,580 on Wednesday, February 7.

Investors sentiment decreased to 0.86 in Q3 2017. Its down 0.33, from 1.19 in 2017Q2. It is negative, as 39 investors sold IDEXX Laboratories, Inc. shares while 196 reduced holdings. 55 funds opened positions while 146 raised stakes. 87.85 million shares or 15.07% more from 76.34 million shares in 2017Q2 were reported. Virtus Investment Advisers stated it has 1,888 shares. Manufacturers Life Company The owns 94,340 shares for 0.02% of their portfolio. The Illinois-based Chicago Equity Prtnrs Limited Company has invested 0.61% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Qs Investors Llc stated it has 5,398 shares or 0.01% of all its holdings. Connable Office Inc holds 5,090 shares. 11,900 are held by Teachers Retirement Sys Of The State Of Kentucky. Boothbay Fund Mgmt Lc reported 1,802 shares. Tekla Capital Management Ltd reported 132,352 shares. Parsons Cap Mgmt Ri has invested 0.04% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Veritable Limited Partnership, Pennsylvania-based fund reported 5,186 shares. Moreover, Tiaa Cref Management Ltd Co has 0.05% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 500,442 shares. King Luther Capital Mgmt Corporation accumulated 0.01% or 4,348 shares. 30,475 were accumulated by Comerica Savings Bank. Globeflex Cap Lp invested 0.09% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Lmr Prtnrs Llp accumulated 8,179 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.